Finlands Akademi
Finansieringsbeslut
 
Namn Rantamäki, Tomi
Organisation HY
Projektets titel Novel rapid-acting antidepressant drug therapies
Beslutnr 305195
Beslutsdatum 30.09.2016
Finansieringsperiod 01.10.2016 - 30.09.2018
Finansiering 298 003
WebFOCUS Report
Beskrivning av projektet
There is a huge unmet medical need for faster acting, safer and more efficient antidepressants. We have identified shared neurobiological correlates induced by rapid-acting antidepressant ketamine and putative other rapid-acting antidepressants (nitrous oxide, flurothyl) in experimental models. In this project, we have 1) established a collaborative network with academic groups, clinicians, commercialization experts and other relevant stakeholders to evaluate the scientific, translational and economic significance of our findings; 2) performed research to understand rapid antidepressant actions and to develop new treatments and efficacy monitors against major depression; and 3) conducted commercialization related activities to understand and increase the value of our invention. We are currently seeking for collaborative parties that aid the translation of our innovations into clinical testing and evaluation.